azithromycin granules
Commercial- Indications
- Pediatric bacterial infections
Company intelligence / Profile preview
Shandong Wit Dyne Health is a specialty pharmaceutical company based in China that focuses primarily on the research, development, and commercialization of pediatric healthcare products. The company is a market leader in children's nutritional supplements and medicines, with its flagship product, Yi Kexin (Vitamin AD drops), holding a significant share of the domestic market. Beyond its core pediatric portfolio, which includes antibiotics, digestive aids, and fever reducers, the company also operates in the information technology and education sectors. Shandong Wit Dyne Health is publicly traded on the Shenzhen Stock Exchange and continues to expand its presence in the specialty pharmaceutical market through innovation and strategic distribution.
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WIT.